Metabolomic analyses in epidemiological studies have demonstrated a strong sexual dimorphism for most metabolites. Cross-sex hormone treatment (CSH) in transgender individuals enables the study of metabolites in a cross-gender setting. Targeted metabolomic profiling of serum of fasting transmen and transwomen at baseline and following 12 months of CSH (N = 20/group) was performed. Changes in 186 serum metabolites and metabolite ratios were determined by targeted metabolomics analysis based on ESI-LC-MS/MS. RandomForest (RF) analysis was applied to detect metabolites of highest interest for grouping of transwomen and transmen before and after initiation of CSH. Principal component analysis (PCA) was performed to check whether group differentiation was achievable according to these variables and to see if changes in metabolite levels could be explained by a priori gender differences. PCA predicted grouping of individuals-determined by the citrulline/arginine-ratio and the amino acids lysine, alanine and asymmetric dimethylarginine - in addition to the expected grouping due to changes in sex steroids and body composition. The fact that most of the investigated metabolites did, however, not change, indicates that the majority of sex dependent differences in metabolites reported in the literature before may primarily not be attributable to sex hormones but to other gender-differences.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105120 | PMC |
| http://dx.doi.org/10.1038/srep37005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cross-Sex Hormone Therapy Is Associated With Loss of Circadian Rhythm in the Male Rat.
Hypertension
February 2025
Department of Physiology and Biophysics (J.H.M., B.F.C., A.Z.R., K.C., A.T.W., B.T.A.), University of Mississippi Medical Center, Jackson.
Background: Transgender women are individuals born male but identify as female. Many transgender women undergo gender-affirming hormone therapy to alleviate the distress that can occur due to gender incongruence. For transgender women, gender-affirming hormone therapy includes 17β-estradiol (E2) combined with an antiandrogen therapy (AA) or surgical intervention.
View Article and Find Full Text PDFHuman-specific protein-coding and lncRNA genes cast sex-biased genes in the brain and their relationships with brain diseases.
Biol Sex Differ
October 2024
Bioinformatics Section, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
Background: Gene expression shows sex bias in the brain as it does in other organs. Since female and male humans exhibit noticeable differences in emotions, logical thinking, movement, spatial orientation, and even the incidence of neurological disorders, sex biases in the brain are especially interesting, but how they are determined, whether they are conserved or lineage specific, and what the consequences of the biases are, remain poorly explored and understood.
Methods: Based on RNA-seq datasets from 16 and 14 brain regions in humans and macaques across developmental periods and from patients with brain diseases, we used linear mixed models (LMMs) to differentiate variations in gene expression caused by factors of interest and confounding factors and identify four types of sex-biased genes.
Gynecological primary care of trans men and transmasculine non-binary individuals, a French descriptive study.
Int J Transgend Health
December 2023
Claude Bernard University Lyon 1, Lyon, France.
Introduction: Gynecological primary care is a public health issue, however, there is no French data on the transmasculine population, despite identified needs and a low coverage rate described in the international literature. The objective was to analyze the access of the French transmasculine population to gynecological primary care.
Methods: The study "Trans men and Transmasculine non-binary individuals use and access to prevention and sexual health care 2022" is a non-interventional, self-administrated, anonymous online study targeting transmasculine adults living in France.
Voice Perception and Mental Health in Transgender Women.
J Voice
October 2024
Endocrine Institute, Tel-Aviv Sourasky Medical Center, Faculty of Medicine and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
Article Synopsis
- The study investigates how voice experience relates to levels of depression and anxiety in transgender women undergoing gender affirmation.
- Conducted with 67 participants, the findings show that those with a more positive voice experience reported lower levels of anxiety and depression, less hoarseness, and higher employment rates.
- No correlation was found between voice experience and medical treatments related to gender affirmation, suggesting that voice adjustment therapy could be beneficial for this population.
Sex-specific post-inflammatory dysbiosis mediates chronic visceral pain in colitis.
Gut Microbes
October 2024
Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Background: Despite achieving endoscopic remission, over 20% of inflammatory bowel disease (IBD) patients experience chronic abdominal pain. Visceral pain and the microbiome exhibit sex-dependent interactions, while visceral pain in IBD shows a sex bias. Our aim was to evaluate whether post-inflammatory microbial perturbations contribute to visceral hypersensitivity in a sex-dependent manner.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!